Adolescent depression and suicide are on the rise, yet effective care is limited by long waitlists and large out-of-pocket costs for therapy, limited pharmacological options, and stigma surrounding mental health.
Limbix Spark is the first prescription digital therapeutic designed to support adolescents with depression. Spark is a multi-week cognitive behavioral therapy based program focused on the completion of value-based activities that spark feelings of pleasure or mastery. Once FDA cleared, Spark will be available for clinicians to prescribe.
Limbix is actively creating prescription digital therapeutics (PDTs) to enable doctors to prescribe digital, evidence-based, therapeutic interventions for adolescent mental health.
Technology is revolutionizing treatment for mental health. Help us design thoughtful digital experiences for current and future generations of young people.
Join our Teen Advisory Council!